BX Swiss TOP 30 CHF
1.185,32
PKT
-2,74
PKT
-0,23
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.11.22 | Nestlé Overweight | Barclays Capital | |
25.11.22 | Nestlé Hold | Deutsche Bank AG | |
25.11.22 | UBS Outperform | RBC Capital Markets | |
24.11.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.11.22 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.11.22 | UBS Hold | Jefferies & Company Inc. | |
23.11.22 | UBS Neutral | JP Morgan Chase & Co. | |
23.11.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
23.11.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
22.11.22 | Novartis Sell | Deutsche Bank AG | |
22.11.22 | Swiss Re Equal Weight | Barclays Capital | |
22.11.22 | Zurich Insurance Overweight | Barclays Capital | |
22.11.22 | Richemont Overweight | Barclays Capital | |
21.11.22 | Givaudan Sell | UBS AG | |
21.11.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
21.11.22 | Richemont Buy | Deutsche Bank AG | |
21.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
21.11.22 | UBS Underweight | Barclays Capital | |
21.11.22 | Nestlé Overweight | Barclays Capital | |
17.11.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
17.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
16.11.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
16.11.22 | Zurich Insurance Buy | UBS AG | |
16.11.22 | Givaudan Underperform | Bernstein Research | |
16.11.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
15.11.22 | UBS Neutral | JP Morgan Chase & Co. | |
15.11.22 | Roche Hold | Deutsche Bank AG | |
14.11.22 | Richemont Neutral | Credit Suisse Group | |
14.11.22 | Roche Outperform | Credit Suisse Group | |
14.11.22 | UBS Hold | Jefferies & Company Inc. | |
14.11.22 | Richemont Buy | UBS AG | |
14.11.22 | Roche Neutral | JP Morgan Chase & Co. | |
14.11.22 | Roche Overweight | Barclays Capital | |
14.11.22 | Roche Buy | Jefferies & Company Inc. | |
14.11.22 | Roche Neutral | UBS AG | |
14.11.22 | Roche Outperform | Bernstein Research | |
14.11.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
14.11.22 | Richemont Outperform | RBC Capital Markets | |
11.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
11.11.22 | Richemont Buy | UBS AG |